corticosteroids
Table of Contents
corticosteroids
also known as glucocorticosteroids
see also:
systemic corticosteroids
adverse effects of high dose systemic corticosteroids
- leukocytosis which may cause a false suggestion of underlying infection
- immune suppression and risk of infections
- do not give a live vaccine if considered immunocompromised!
- patients are generally considered immunocompromised from steroids if either:
- short or long term daily or alternating daily doses of prednisolone > 20mg or equivalent, or,
- less than 1 month after ceasing a prolonged course of high dose steroids (eg > 20mg prednisolone for more than 2 weeks)
- patients with the following are generally regarded as being immunocompetent if:
- lower doses than the above
- inhaled steroids
- steroid injections eg i/articular
- physiologic maintenance doses
- delayed wound healing
- instability of diabetes, hyperglycaemia
- neurocognitive effects - may cause delirium or psychosis
- longer term use or very high doses are associated with risk of spontaneous avascular bone necrosis (osteonecrosis / avascular necrosis bone (AVN)) eg. hip or knee
- adreno-cortical axis suppression - risk of Addisonian crisis on sudden cessation hence need for weaning doses if more than 3 day course
- hypokalemic alkalosis
- vertigo
- gastritis
adverse effects of long term low to medium dose systemic corticosteroids
- immune suppression and risk of infections
- delayed wound healing
- instability of diabetes, hyperglycaemia
- osteonecrosis / avascular necrosis bone (AVN) - cumulative dose appears to be important risk
- adreno-cortical axis suppression
- thinning of skin
- easy bruising, epistaxis
- acne
- Cushingoid effects
- male-pattern hair growth in females
- glaucoma, cataracts
- depression, delirium
- gastritis
- myopathy
- cardiomyopathy
- reactivation of latent tuberculosis (TB)
usual doses
oral prednisolone
- come in 5mg and 25mg tablets or a liquid formulation for children
- usual initial children's dose is 0.5-2mg/kg/day to max. 25-50mg/d
- usual initial adult dose 25-50mg/day
- dose may be much higher for some conditions such as initial Mx of multiple sclerosis (MS)
IV dexamethasone
- usual adult dose is 8mg IV per day
IV hydrocortisone
- usual adult and childrens dose is:
- 1-2 mg/kg (max. 250mg) intravenously (IV) every 6 hours initially for 24 hours;
- maintenance: 0.5-1 mg/kg every 6 hours
topical corticosteroids
- AVOID high potency or super-potent preparations on areas of thin skin such as the face, flexures, scrotum and eyelids
- Take great care when using in occlusive dressings, in children (do not use on nappy region as occluded dressing) and, in the elderly
- Should NOT be used on denuded skin
- AVOID long periods of Rx - no longer than 2 wks on the face and 3-4 wks elsewhere - longer treatments should have steroid-free breaks of a few days to a week to reduce tachphylaxis.
- Should NOT be used for infected skin, acne rosacea, acne vulgaris or perioral dermatitis
- AVOID more than 45g/week of potent or more than 100g/wk of moderately potent steroid to minimise systemic effects in adults.
- AVOID potent steroids in pregnancy as systemic absorption may cause fetal abnormality in animal studies
- Most applications can be daily or bd, but where it is wiped off, may require more frequent applications
general usage guidelines
- lotions are preferred for children (as more permeable skin), on hairy skin and for extensive areas but require shaking
- creams are less greasy than ointments, easy to spread and washable in water
- ointments provide the highest drug penetration and increase the potency
- whole body application requires 30-40g per application!
- one hand application requires 0.3g per application
adverse effects
- skin atrophy with possible scarring and ulceration
- increased skin transparency and brightness
- telangectasia
- striae
- easy bruising
- delayed wound healing
- faster spread of skin infections
- hypopigmentation
- glaucoma if used near the eye
- contact hypersensitivity to preservatives
- tachyphylaxis
- systemic effects if extensive skin areas
classification based upon potency
super-potent - class 1 USA / UK
- 0.05% betamethasone dipropionate as ointment in optimised vehicle
- 0.05% clobetasol propionate
high potency - class 2/3 USA, class II UK
- 0.05% betamethasone dipropionate ointment
- 0.1% betamethasone valerate ointment
- 0.1% mometasone furoate ointment or cream
- the best option for chronic, hyperkeratotic, lichenified or indurated lesions such as:
- palmo-plantar psoriasis
- lichen planus
- lichen simplex chronicus
moderate potency - class 4/5 USA, class III UK
- 0.05% betamethasone dipropionate cream or lotion
- 0.05% betamethasone valerate ointment or cream
- 0.1% triamcinolone acetonide cream
- 0.1% methylprednisolone aceponate ointment, cream or lotion
- 0.05% clobetasone cream
- the best option for:
- psoriasis other than intertriginous
- adult atopic dermatitis
- nummular eczema
low potency
- 0.5% or 1% hydrocortisone or hydrocortisone acetate
- 0.05% desonide
- the best option for areas of thin skin such as:
- children's atopic dermatitis
- seborrheic dermatitis
- intertriginous psoriasis
- other intertrigos
corticosteroids.txt · Last modified: 2021/10/28 01:52 by gary1